Medical apparatus and instruments for use in diagnosing and monitoring vital signs of patients with psychiatric and neurological disorders and diseases, dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and dependency; injection devices for pharmaceuticals, syringes and needles for injections and medical purposes; integrated medical systems, namely, medical diagnostic imaging apparatus and software sold as a unit therewith for managing, measuring, monitoring, assessing, controlling, collecting, storing and examining patient and client data and information captured by the medical system in web-based physical, psychological and neurological examinations conducted at a distance and at a clinic; medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems

Class [005]
Pharmaceutical Products

Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy; pharmaceutical preparations and substances for the prevention and treatment of Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and dependency; diagnostic agents, reagents, preparations and substances for medical purposes

Mark Details

Serial Number

No 87650703

Mark Type

No Service/Collective Mark

Attorney Docket Number

No LU-NUZALMA

44D Filed

44D Current

44E filed

44E Current

66A Filed

66A Current

Current Basis

No Basis

Legal History

Status Date	Action Taken
11^th Feb 2019	ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
11^th Feb 2019	ABANDONMENT - NO USE STATEMENT FILED
10^th Jul 2018	NOA E-MAILED - SOU REQUIRED FROM APPLICANT
15^th May 2018	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15^th May 2018	PUBLISHED FOR OPPOSITION
25^th Apr 2018	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09^th Apr 2018	ASSIGNED TO LIE
02^th Apr 2018	APPROVED FOR PUB - PRINCIPAL REGISTER
28^th Mar 2018	EXAMINER'S AMENDMENT ENTERED
28^th Mar 2018	NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

NUZALMA

Classification Information

Class [010]Medical Instrument Products

Class [005]Pharmaceutical Products